These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 11320346)
1. [Selective estrogen receptor modulators as a new concept in preventing health risks of menopause]. Vokrouhlická J; Pavo I; Stĕpán J Cas Lek Cesk; 1998 Nov; 137(22):679-85. PubMed ID: 9929934 [TBL] [Abstract][Full Text] [Related]
2. Addressing postmenopausal estrogen deficiency: a position paper of the American Council on Science and Health. Shapiro S MedGenMed; 2001 Jan; ():E7. PubMed ID: 11320346 [TBL] [Abstract][Full Text] [Related]
3. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
4. Effects of estrogens and selective estrogen receptor modulators on indicators of cardiovascular health in postmenopausal women. Klein KP; Herrington DM Medscape Womens Health; 2002; 7(5):2. PubMed ID: 12466731 [No Abstract] [Full Text] [Related]
5. [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives]. Simoncini T; Mannella P; Genazzani AR Recenti Prog Med; 2003 Feb; 94(2):51-6. PubMed ID: 12908369 [TBL] [Abstract][Full Text] [Related]
6. [Role of estrogen and selective estrogen receptor modulators in anti-aging]. Ohta H Clin Calcium; 2008 Jul; 18(7):986-94. PubMed ID: 18591752 [TBL] [Abstract][Full Text] [Related]
7. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease. Koledova VV; Khalil RA Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655 [TBL] [Abstract][Full Text] [Related]
8. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Dubey RK; Imthurn B; Barton M; Jackson EK Cardiovasc Res; 2005 May; 66(2):295-306. PubMed ID: 15820198 [TBL] [Abstract][Full Text] [Related]